Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GXQ

Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-1335

6GXQ の概要
エントリーDOI10.2210/pdb6gxq/pdb
分子名称Phosphodiesterase, MAGNESIUM ION, ZINC ION, ... (7 entities in total)
機能のキーワードparasitic phosphodiesterase, hydrolase, african trypanosomiasis, sleeping sickness
由来する生物種Trypanosoma brucei
タンパク質・核酸の鎖数2
化学式量合計82453.29
構造登録者
Singh, A.K.,Brown, D.G. (登録日: 2018-06-27, 公開日: 2019-07-10, 最終更新日: 2024-01-17)
主引用文献de Heuvel, E.,Singh, A.K.,Boronat, P.,Kooistra, A.J.,van der Meer, T.,Sadek, P.,Blaazer, A.R.,Shaner, N.C.,Bindels, D.S.,Caljon, G.,Maes, L.,Sterk, G.J.,Siderius, M.,Oberholzer, M.,de Esch, I.J.P.,Brown, D.G.,Leurs, R.
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2).
Bioorg.Med.Chem., 27:4013-4029, 2019
Cited by
PubMed Abstract: Inhibitors against Trypanosoma brucei phosphodiesterase B1 (TbrPDEB1) and B2 (TbrPDEB2) have gained interest as new treatments for human African trypanosomiasis. The recently reported alkynamide tetrahydrophthalazinones, which show submicromolar activities against TbrPDEB1 and anti-T. brucei activity, have been used as starting point for the discovery of new TbrPDEB1 inhibitors. Structure-based design indicated that the alkynamide-nitrogen atom can be readily decorated, leading to the discovery of 37, a potent TbrPDEB1 inhibitor with submicromolar activities against T. brucei parasites. Furthermore, 37 is more potent against TbrPDEB1 than hPDE4 and shows no cytotoxicity on human MRC-5 cells. The crystal structures of the catalytic domain of TbrPDEB1 co-crystalized with several different alkynamides show a bidentate interaction with key-residue Gln874, but no interaction with the parasite-specific P-pocket, despite being (uniquely) a more potent inhibitor for the parasite PDE. Incubation of blood stream form trypanosomes by 37 increases intracellular cAMP levels and results in the distortion of the cell cycle and cell death, validating phosphodiesterase inhibition as mode of action.
PubMed: 31378593
DOI: 10.1016/j.bmc.2019.06.026
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.96 Å)
構造検証レポート
Validation report summary of 6gxq
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon